Meeting
2014 ASCO Annual Meeting
An updated systematic review and meta-analysis of randomized controlled trials on duration of chemotherapy for advanced non-small cell lung cancer.
Authors
Yu Yang Soon
National University Cancer Institute, Singapore, Singapore
Yu Yang Soon , Martin R. Stockler , Lisa Askie , Michael J. Boyer
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer - Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 8104)
DOI
10.1200/jco.2014.32.15_suppl.8104
Abstract #
8104
Poster Bd #
285
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Progression-free survival as a surrogate endpoint of overall survival in advanced biliary tract cancer: A meta-analysis of randomized trials and individual-patient level correlation.
First Author: Carles Fabregat Franco
Poster
2019 ASCO-SITC Clinical Immuno-Oncology Symposium
Checkpoint inhibitors in combination with chemotherapy for first-line treatment of advanced nonsquamous non-small cell lung cancer: A systematic review and meta-analysis of randomized controlled trials (RCTs).
First Author: Wai Lin Thein
Poster
2017 Gastrointestinal Cancers Symposium
Role of cetuximab in conversion therapy in advanced KRAS WT colorectal cancer with liver limited disease: A systematic review and meta-analysis.
First Author: Michelle McMullen
Poster
2013 ASCO Annual Meeting
Multitargeted antiangiogenic tyrosine kinase inhibitors in advanced non-small cell lung cancer: A meta-analysis of randomized controlled trials.
First Author: Wenhua Liang